Follow
Rossella Marullo
Rossella Marullo
Weill Cornell Medicine
Verified email at med.cornell.edu
Title
Cited by
Cited by
Year
Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions
R Marullo, E Werner, N Degtyareva, B Moore, G Altavilla, SS Ramalingam, ...
PloS one 8 (11), e81162, 2013
7692013
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
F Cayrol, P Praditsuktavorn, TM Fernando, N Kwiatkowski, R Marullo, ...
Nature communications 8 (1), 14290, 2017
1022017
HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer …
R Marullo, E Werner, H Zhang, GZ Chen, DM Shin, PW Doetsch
Carcinogenesis 36 (11), 1397-1406, 2015
972015
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas
B Culjkovic-Kraljacic, TM Fernando, R Marullo, N Calvo-Vidal, A Verma, ...
Blood, The Journal of the American Society of Hematology 127 (7), 858-868, 2016
902016
Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients
B Pera, T Tang, R Marullo, SN Yang, H Ahn, J Patel, R Elstrom, J Ruan, ...
Clinical Epigenetics 8, 1-10, 2016
442016
Combination therapy targeting BCL6 and phospho-STAT3 defeats intratumor heterogeneity in a subset of non–small cell lung cancers
D Deb, S Rajaram, JE Larsen, PD Dospoy, R Marullo, LS Li, K Avila, ...
Cancer research 77 (11), 3070-3081, 2017
412017
BCL6 evolved to enable stress tolerance in vertebrates and is broadly required by cancer cells to adapt to stress
TM Fernando, R Marullo, B Pera Gresely, JM Phillip, SN Yang, ...
Cancer discovery 9 (5), 662-679, 2019
342019
Metabolomic profiling reveals cellular reprogramming of B-cell lymphoma by a lysine deacetylase inhibitor through the choline pathway
B Pera, J Krumsiek, SE Assouline, R Marullo, J Patel, JM Phillip, L Román, ...
EBioMedicine 28, 80-89, 2018
282018
The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases
R Marullo, M Castro, S Yomtoubian, MN Calvo-Vidal, MV Revuelta, ...
Science advances 7 (45), eabg1964, 2021
222021
Oncogenic HSP90 facilitates metabolic alterations in aggressive B-cell lymphomas
MN Calvo-Vidal, N Zamponi, J Krumsiek, MA Stockslager, MV Revuelta, ...
Cancer research 81 (20), 5202-5216, 2021
192021
Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma
E Ricker, A Verma, R Marullo, S Gupta, C Ye, T Pannellini, M Manni, ...
Scientific Reports 10 (1), 13094, 2020
92020
Procedure for developing linear and Bayesian classification models based on immunosensor measurements
S Mobley, S Yalamanchili, H Zhang, R Marullo, ZG Chen, CS Moreno, ...
Sensors and Actuators B: Chemical 190, 165-170, 2014
82014
Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas
R Marullo, SC Rutherford, JP Leonard, L Cerchietti
Cell Cycle 15 (17), 2241-2247, 2016
52016
Abstract LB-062: XPO1 is a rational target for double and triple-hit aggressive B-cell lymphomas
R Marullo, SN Yang, T Rashal, Y Landesman, R Carlson, S Shacham, ...
Cancer research 75 (15_Supplement), LB-062-LB-062, 2015
52015
A phase I study of selinexor and R-ICE in patients with relapsed/refractory aggressive B-cell lymphomas
SC Rutherford, JN Allan, J Ruan, RR Furman, K Richards, A Rodriguez, ...
Blood 136, 7-8, 2020
42020
XPO1 enables adaptive regulation of mRNA export required for genotoxic stress tolerance in cancer cells
R Marullo, SC Rutherford, MV Revuelta, N Zamponi, B Culjkovic-Kraljacic, ...
Cancer Research 84 (1), 101-117, 2024
32024
The transcription factor BCL6 is a rational target in non-small cell lung cancer (NSCLC)
R Marullo, H Ahn, M Cardenas, A Melnick, F Xue, L Cerchietti
Cancer Research 76 (14_Supplement), 1271-1271, 2016
32016
Inhibition of integrin αVβ3 signaling improves the antineoplastic effect of bexarotene in cutaneous T-cell lymphoma
F Cayrol, MV Revuelta, M Debernardi, A Paulazo, JM Phillip, N Zamponi, ...
Molecular cancer therapeutics 21 (9), 1485-1496, 2022
22022
Aging-Associated Epigenetic Reprogramming Alters the Germinal Center Reaction and Targets Pathways Related to Lymphomagenesis
R Marullo, MV Revuelta, W Béguelin, J Lara-Garcia, L Cerchietti
Blood 138, 676, 2021
22021
Development of a Novel Class of Microtubule Destabilizing Agents with Selectivity Against Diffuse Large B-Cell Lymphoma (DLBCL) with B-Cell Receptor (BCR) Activation
BP Gresely, F de Asís Balaguer, MG Cardenas, MV Revuelta, MNC Vidal, ...
Blood 130, 2546, 2017
22017
The system can't perform the operation now. Try again later.
Articles 1–20